Characteristic | Bladder cancer cases (n=50)* | Other cohort members (n=1762) | Test for difference |
---|---|---|---|
Gender | |||
Male, n (%) | <50† | 1629 (92) | |
Female, n (%) | <5† | 133 (8) | Fisher's exact p=0.17 |
Race | |||
White, n (%) | 34 (68) | 715 (41) | |
Non-white, n (%) | 0 | 76 (4) | |
Unknown, n (%)‡ | 16 (32) | 971 (55) | p=0.0004 |
Year of birth | |||
Median (range) | 1932 (1914–1956) | 1948 (1891–1979) | Wilcoxon p<0.0001 |
Duration of employment (years)§ | |||
Mean (SD) | 20.4 (11.0) | 8.1 (11.7) | |
Median (range) | 22.0 (0.3–37.5) | 1.4 (0.005–45.5) | Wilcoxon p<0.0001 |
Cumulative rank (unit-years)§ | |||
Mean (SD) | 100.0 (74.6) | 28.2 (49.8) | |
Median (Range) | 78.5 (0.8–296.7) | 4.4 (0–296.9) | Wilcoxon p<0.0001 |
Exposure group | |||
Probably not exposed, n (%) | 5 (10) | 557 (32) | |
Probably exposed (low and irregularly/occasionally), n (%) | 5 (10) | 150 (9) | |
Probably exposed (low and regularly), n (%) | 5 (10) | 190 (11) | |
Definitely exposed (moderate/high), n (%) | 35 (70) | 865 (49) | χ23df p=0.0083 |
*Cases included ICD-O codes 8010, 8070, 8120, 8130 and 8140. They included 38 malignant/invasive cancers and 14 urothelial carcinoma in situ or non-invasive papillary urothelial carcinoma (<5 in this last category).
†Counts in individual cells with fewer than 5 observations, or where fewer than 5 observations can be inferred, were not provided, to protect worker confidentiality.
‡Race/ethnicity was not available for some cohort members. For the analysis, race was assumed to be Caucasian, based on demographics in the geographic area.
§Duration of employment and cumulative rank through date of diagnosis for cases.
ICD, International Classification of Diseases.